en · de · es · pt
lab-handbook.peptides6908.com › News › Identity And Regulatory Status — Research Overview

Identity And Regulatory Status — Research Overview

By Editorial Desk · published 2025-09-12 · last reviewed 2025-10-18 · News

A practical reference on PPARδ: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

Reviewed 2025-10-18. Anything still debated is marked as such rather than presented as settled.

Identity and Regulatory Status

Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.

Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.

Regulation and Detection

Cardarine has no approved therapeutic indication and is not marketed as a medicine. The World Anti-Doping Agency lists GW501516 as a prohibited substance at all times, covering both in-competition and out-of-competition periods. National laws vary: some countries treat it as an unapproved drug subject to import controls, while others have specific restrictions on sale for human consumption. It is often sold as a research chemical, a label that does not imply safety or legality. Enforcement actions have targeted online vendors and shipments.

Anti-doping laboratories identify GW501516 and related metabolites using liquid chromatography coupled with tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be analyzed. The method targets the parent compound and phase I and phase II metabolites, which extend the detection window. Because the substance is prohibited at all times, athletes can be tested outside competition. Detection limits and windows depend on the assay, sample type, and individual metabolism.

Cardarine is frequently described as a fat-burning or endurance-enhancing supplement, but these claims exceed the available evidence. The compound is not a hormone, steroid, or selective androgen receptor modulator. Research articles discuss it as a tool compound for studying PPARδ biology, while anti-doping literature focuses on its abuse and detection. Quality of unapproved products is uncertain, and independent analyses have found impurities or incorrect labeling. Open questions include whether human cancer risk resembles that seen in rodents and how often non-athletes use the substance.

Cardarine at a glance

PropertyValueNotes
Common synonymsGW501516; GW-1516; endurobolGW501516 is the research code
Drug classPPARδ agonistNot a selective androgen receptor modulator
Molecular formulaC21H18F3NO3S2Established chemical formula
Molar mass453.5 g/molCalculated from the formula
Regulatory statusProhibited in sport; not approved as medicineStatus varies by country

Mechanism and Safety Research

Early clinical research explored GW501516 for lipid disorders, obesity, and diabetes. Some short-term human studies reported changes in HDL cholesterol, LDL cholesterol, and triglycerides. The development program was discontinued after rodent studies showed dose-dependent tumor formation in multiple tissues, including liver, bladder, stomach, and skin. These findings raised concerns about long-term cancer risk in humans. Because human exposure data are limited, the clinical significance of the rodent tumors remains uncertain.

Literature on cardarine often separates receptor pharmacology from toxicology. Mechanistic papers describe PPARδ activation and gene expression changes, while safety assessments focus on carcinogenicity and species differences. Questions remain about whether rodent tumors arise through PPARδ-dependent or off-target mechanisms. Another open area is how human metabolism and exposure compare with those in animal studies. Analytical methods such as liquid chromatography–mass spectrometry are used to confirm identity in biological and product samples.

GW501516 acts as an agonist at the peroxisome proliferator-activated receptor delta, a nuclear receptor that regulates gene expression. Activation shifts transcription toward genes involved in fatty acid uptake, oxidation, and energy expenditure. The compound does not bind the androgen receptor and therefore differs from anabolic steroids and SARMs. In rodent models, this metabolic shift has been linked to increased running endurance and reduced fat accumulation. The exact downstream pathways in humans remain incompletely characterized.

Related pages on this site

Background and Regulatory Status

Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.

Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.

Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.

Further detail

==== 900–999 ==== Act of Sederunt (Rules of the Court of Session Amendment No. 2) (Fees of Solicitors) 1993 (S.I. 1993/900) Further Education (Exclusion of Land from Transfer) Order 1993 (S.I. 1993/901) Greater Manchester and Lancashire (County and Metropolitan Borough Boundaries) Order 1993 (S.I. 1993/902) Dyfed-Powys Police (Amalgamation) (Amendment) Order 1993 (S.I. 1993/909) National Rivers Authority (Anglian Region) (Reconstitution of the Witham Third District Internal Drainage Board) Order 1993 (S.I. 1993/910) Plymouth Development Corporation (Area and Constitution) Order 1993 (S.I. 1993/911) Electricity (Restrictive Trade Practices Act 1976) (Exemption) Order 1993 (S.I. 1993/912) Child Support (Miscellaneous Amendments) Regulations 1993 (S.I. 1993/913) Act of Sederunt (Child Support Act 1991) (Amendment of Ordinary Cause and Summary Cause Rules) 1993 (S.I. 1993/919) Act of Sederunt (Child Support Rules) 1993 (S.I. 1993/920) Act of Sederunt (Bankruptcy Rules) 1993 (S.I. 1993/921) Land Registration (Scotland) Act 1979 (Commencement No. 7) Order 1993 (S.I. 1993/922) Dairy Produce Quotas Regulations 1993 (S.I. 1993/923) Education (Dissolution of the Council for National Academic Awards) Order 1993 (S.I. 1993/924) Child Support (Maintenance Assessments and Special Cases) Amendment Regulations 1993 (S.I. 1993/925) Greater Manchester and Lancashire (County and District Boundaries) Order 1993 (S.I. 1993/926) Secure Tenancies (Designated Courses) (Amendment) Regulations 1993 (S.I.

A snakebite is an injury caused by the bite of a snake. Most snake species are non-venomous, but bites from venomous snakes may result in envenomation, in which venom is injected into the victim. A common sign of a bite from a venomous snake is the presence of two puncture wounds from the animal's fangs. Envenomation may cause redness, swelling, and severe pain around the bite, which may take up to an hour to develop. Vomiting, blurred vision, tingling of the limbs, and sweating may result. Most bites are on the hands, arms, or legs. Fear following a bite is common with symptoms of a racing heart and feeling faint. The venom may cause bleeding, kidney failure, a severe allergic reaction, tissue death around the bite, or breathing problems. Bites may result in the loss of a limb or other chronic problems or even death. The outcome depends on the type of snake, the area of the body bitten, the amount of snake venom injected, the general health of the person bitten, and whether or not anti-venom serum has been administered in a timely manner. Problems are often more severe in children than adults, due to their smaller size. Allergic reactions to snake venom can further complicate outcomes and can include anaphylaxis, requiring additional treatment and in some cases resulting in death. Snakes bite acts both as a method of hunting and as a means of protection. Risk factors for bites include working outside with one's hands such as in farming, forestry, and construction.

=== Witnesses === Afraid of being kidnapped and missing Mendonça, one of the boy's friend at school tried to commit suicide, two months after the disappearance. In the crime's reconstitution, Dias could not explain what he did between 14 (2 P.M) and 18 (6 P.M) hours on the day Mendonça disappeared. With the reconstitution it was proven that the investigation let leads and important witnesses slip by. The inspectors did not want to explain to the press the reason why they devalued Alcina Dias' testimony. A man that worked in a gas station guaranteed that at the time of the disappearance he saw Mendonça, in the centre of the village of Lousada, walking next to two other boys. The court questioned the witness about his statements to the GNR the day following the disappearance, where he said he saw two children passed by on bikes, but that neither was Mendonça. The witness insisted that he could not remember giving the testimony to GNR, even thought his signature was in the records. They also heard a witness that said they saw Mendonça's bicycle at 16 (4 P.M) hours. Without being identified, a boy that was 14 at the time of the disappearance, told RTP that PJ did not value the different testimonies given to the police. The witness, along with four other young people, was waiting for Mendonça to arrive to play football. When Mendonça got there he said he was not going to play anymore, hid his bike and got in the car. In 2003, in the Casa Pia Process, a man said that he was with Mendonça in a pension for sexual meetings, in the end of January 2001.

Sources: en.wikipedia.org

Supporting material

Montebello High School is a public high school which is part of the Montebello Unified School District. Founded in 1909, it has an enrollment of approximately 2,600 students in grades 9-12. Its campus is located in Montebello, California, a suburb of Los Angeles. It is named for the city of Montebello.

==== Absorption ==== Pregabalin is absorbed from the intestines by an active transport process mediated via the large neutral amino acid transporter 1 (LAT1, SLC7A5), a transporter for amino acids such as L-leucine and L-phenylalanine. Few (less than 10 drugs) are known to be transported by this transporter. Unlike gabapentin, which is transported solely by the LAT1, pregabalin seems to be transported by the LAT1 and by other carriers as well. The LAT1 is easily saturable, so the pharmacokinetics of gabapentin are dose-dependent, with diminished bioavailability and delayed peak levels at higher doses. In contrast, this is not the case for pregabalin, which shows linear pharmacokinetics and no saturation of absorption. The oral bioavailability of pregabalin is greater than or equal to 90% across and beyond its entire clinical dose range (75 to 600 mg/day). Food does not significantly influence the oral bioavailability of pregabalin. Pregabalin is rapidly absorbed when administered on an empty stomach, with a Tmax (time to peak levels) of generally less than or equal to 1 hour at doses of 300 mg or less. Food has been found to substantially delay the absorption of pregabalin and to significantly reduce peak levels without affecting the bioavailability of the drug; Tmax values for pregabalin of 0.6 hours in a fasted state and 3.2 hours in a fed state (5-fold difference), and the Cmax is reduced by 25–31% in a fed versus fasted state.

For each essential amino acid i, calculate ⁠Ti/Ri⁠. Take the amino acid with the smallest value of ⁠Ti/Ri⁠. Call it l. This is the limiting amino acid. The AAS is 100% × ⁠Tl/Rl⁠. PDCAAS estimates digestibility in a separate procedure. The estimated PD is multiplied with AAS to get PDCAAS.

A coronary occlusion, or coronary artery disease, is the partial or complete obstruction of blood flow in a coronary artery. This condition was first discussed in 1910 by Sir William Osler. This condition slows or blocks the supply of oxygen-rich blood to the heart. This condition can lead to myocardial ischemia and if untreated, may cause a heart attack and heart failure. It is the most common form of cardiovascular disease, and is the leading cause of death in the United States, affecting 18 million adults or about 5% of the population.

Sources: en.wikipedia.org

Notes from published material

After authorizing the Pentagon to use military force against Latin American drug cartels, the Trump administration doubled the reward for the capture of Maduro to US$50 million. At the time, an anonymous US official told Reuters that military action against those groups did not seem imminent; another official told Reuters that powers granted in the order included allowing the Navy to carry out sea operations including drug interdiction and targeted military raids. In August 2025, the US began deploying warships and personnel to the Caribbean, citing the need to combat drug cartels, although most of the fentanyl entering the US is over land via Mexico. On 20 August, Trump ordered three Navy warships to the coast of South America. As of 29 August, seven US warships, along with one nuclear-powered fast attack submarine, were in and around the Southern Caribbean, bringing along more than 4,500 sailors and marines. The Central Intelligence Agency joined the military campaign after confirming that it would play a significant role in combating drug cartels, just as it is considering using lethal force against these criminal organizations. In response to this tension in United States–Venezuela relations, Venezuela said it would mobilize more than four million soldiers in the Bolivarian Militia. On 26 August, Defense Minister Vladimir Padrino López announced a naval deployment around Venezuela's main oil hub. Maduro said he "would constitutionally declare a republic in arms" if the country were attacked by the US forces deployed in the Caribbean.

The reactive Leidenfrost effect with cellulose will occur in numerous high temperature applications with carbohydrate polymers, including biomass conversion to biofuels, preparation and cooking of food, and tobacco use. The Leidenfrost effect has also been used as a means to promote chemical change of various organic liquids through their conversion by thermal decomposition into various products. Examples include decomposition of ethanol, diethyl carbonate, and glycerol.

==== Japan ==== Japan has over 100 think tanks, most of which cover not only policy research but also economy, technology and so on. Some are government related, but most of the think tanks are sponsored by the private sector.

Sources: en.wikipedia.org

Frequently asked questions

Is cardarine a SARM?

No. Cardarine is GW501516, a PPARδ agonist, while SARMs act on androgen receptors. The two classes are often grouped in informal discussions despite different mechanisms.

Is cardarine approved for human use?

No. It has no approved medical indication in any country. Regulatory agencies have not cleared it for treatment or prevention of any condition.

Why was its development discontinued?

Early clinical work stopped after rodent carcinogenicity findings. Those animal results raised concerns about long-term human risk, although direct human evidence is lacking. The human relevance of the tumors remains an open scientific question.

Is cardarine legal?

Legal status varies by country. It is not approved as a medicine, and it is prohibited in sport. Some jurisdictions restrict import, sale, or possession.

Network